Login to Your Account



Arginox Phase III Targeting Cardiogenic Shock Patients

By Randall Osborne


Wednesday, June 29, 2005
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription